The Impact of the Energy BRO2 Trial on Local Therapy for Metastatic Breast Cancer

Stephen Chamara is a professor of radiation and cellular oncology at the University of Chicago. He discussed management strategies for patients with oligo metastatic breast cancer. The energy BRO2 trial was to really design a good phase three trial to actually test if this intervention actually helps or not, he said.